Published in Vaccine Weekly, December 28th, 2005
"Insect sting allergy is a common condition with a risk of life-threatening anaphylaxis. After a severe reaction, the fear of being re-stung can significantly reduce quality of life. Venom immunotherapy (VIT) is a highly effective treatment of the underlying type I-sensitization. [Our] review addresses the mechanisms of immune modulation by VIT and outlines current clinical application," investigators in Germany report.
"Although highly effective in the majority of patients, VIT fails in a few individuals," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.